Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 076122

Expand all

MIRTAZAPINE (MIRTAZAPINE)
15MG
Marketing Status: Prescription

Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076122
Product Number: 001
Approval Date: Jun 19, 2003
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

MIRTAZAPINE (MIRTAZAPINE)
30MG
Marketing Status: Prescription

Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076122
Product Number: 002
Approval Date: Jun 19, 2003
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

MIRTAZAPINE (MIRTAZAPINE)
45MG
Marketing Status: Prescription

Active Ingredient: MIRTAZAPINE
Proprietary Name: MIRTAZAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 45MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A076122
Product Number: 003
Approval Date: Jun 19, 2003
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information